Early-stage Capital Fund for Advanced Therapy Tech Start-ups

Our experienced team and advisors have extensive relationships with both potential portfolio companies and purchasers for exits in the Advanced Therapy space, providing global coverage and invaluable expertise in key Advanced Therapy developments worldwide.

We prioritize early-stage companies driving innovation in Advanced Therapy technologies, aiming to reduce costs, save time, and enhance accessibility. Our tech-focused strategy capitalizes on our global team's unique strengths and extensive industry experience, granting us a competitive edge in a less saturated market.

We focus on Advanced Therapy related tools and enabling technologies, including critical reagents, assays, and diagnostics. Additionally, we invest in systems for the manufacturing and logistics supply chain, analytical technologies, and data capture (raw material, in-process, and final release). Machine learning and artificial intelligence are also key areas of our investment focus.

Our fund requires a minimum investment of US$250,000, and our objective is to build a diversified portfolio with 12-15 fund investments. We allocate a quarter of the fund for follow-on investments, and our ongoing engagement is designed to enhance the potential for higher-value exits.

We utilize a global network to source, build, and scale premier portfolio companies. With a strong track record and active relationships with 100+ key players in the global Advanced Therapy arena, we are well-positioned to drive success.

Our unique value creation model, especially Altius Bioventures Racer accelerator program, actively supports our start-ups for higher success rates. Each portfolio company has an ABV Fund partner assigned and our unique team of portfolio advisors significantly adds value to our portfolio.

Our approach emphasizes rigorous methods, validation, and thorough data analysis for evaluating potential investments and managing portfolios. We use a structured process to validate opportunities, employing a robust risk mitigation model.

We emphasize and integrate diversity, equality, and inclusion as core principles within our investment portfolio. Our commitment extends beyond financial metrics, reflecting a conscious effort to support businesses that reflect a rich mosaic of backgrounds and experiences.